# Binosto

NDC: 70539-400
Generic name: alendronate sodium
Labeler / Manufacturer: Radius Health, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, EFFERVESCENT
Routes: ORAL
Marketing started: 20120312

FDA application: NDA202344

## Active ingredients

- ALENDRONATE SODIUM: 91.37 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70539-400"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70539-400
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=09765234-01bc-40f7-b9bb-c167056f3909